NUIG/CON342/15 - Media for Stem Cells - Multi-Party Framework Agreement

The 4-year project, entitled “Role of NRXN1 in neurodevelopmental disorders: from stem cells to clinical phenotypes”, is funded by Science Foundation Ireland (SFI). One of the aims includes the generation of human induced pluripotent stem cells from patients with specific lesions in NRXN1, a gene commonly associated with autism and schizophrenia. It is envisaged that this multi-collaborative, multinational programme will provide human in vitro models for neurodevelopmental disorders, investigate the underlying neuropathological mechanism(s), and, ultimately, identify novel treatment strategies. To this end, we rely on the use of specialised media that supports the growth and expansion of human induced pluripotent stem cells. The purpose of this tender is to establish a Multi-Party Framework Agreement for the supply of Stem Cell Media. It is envisaged that the top 3 scoring tenderers will be appointed to the framework for this tender. On each case a purchase is required; a mini tender competition will be conducted among the suppliers. It is envisaged that the Framework will be established for 2 years with the option to extend annually for another two years. Full details of requirements are provided in the Invitation to Tender document which is available for downloading via www.etenders.gov.ie. Once the Contract Notice is selected, suppliers must "accept" the invitation in order to access the tender documentation. Suppliers must be registered on the etenders website in order to access the information. Registration is free of charge.

Supplies

26/11/2015 10:00:00

24000000-4  Chemical products


University of Galway
University Road, H91 TK33
Galway
Ireland
View profile

NUI Galway Tenders
http://www.universityofgalway.ie

Published notices
Contract Notice (eTenders) 16/10/2015 16:10
Contract notice (TED (v208)) 16/10/2015 15:40
Contract Award Notice (eTenders) 08/02/2017 14:40
Contract award notice (TED (v209)) 07/02/2017 15:40
Lots
Media for Stem Cells - Multi-Party Framework Agreement
Additional information:
Documents Documents
Close